1.      Abbassi-Ghanavati M, Alexander JM, McIntire DD et al. Neonatal effects of magnesium sulfate given to the mother. Obstet Gynecol. 2012;119(1):59–65. doi:10.1097/AOG.0b013e31823b3c3a

2.      Abicht A, Müller JS, Lochmüller  H et al. Congenital myasthenic syndromes. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2021 [cited 2025 Sep 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1168/

3.      Ahmed MI, Iqbal M, Hussain N. A structured approach to the assessment of a floppy neonate. Pediatr Ann. 2016;45(4):e129–e134. doi:10.3928/19382359-20160322-01. Available from: https://pubmed.ncbi.nlm.nih.gov/27195025/

4.      American Academy of Pediatrics. Developmental Characteristics of Preterm Infants. Pediatr Rev. 2008;29(2):67–74

5.      Bardhan M. Neonatal myasthenia gravis. StatPearls. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558935/

6.      Bertini E, D’Amico A, Gualandi F et al. Congenital muscular dystrophies: a brief review. Pediatr Neurol. 2011;45(2):1–10. doi:10.1016/j.pediatrneurol.2011.05.004. Available from: https://pubmed.ncbi.nlm.nih.gov/22172424/

7.      Bird TD. Charcot-Marie-Tooth Hereditary Neuropathy Overview. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2024 Apr 11 [cited 2025 Sep 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1358/

8.      Cacciatore TW, Anderson DI, Cohen RG. Central mechanisms of muscle tone regulation. Front Neurosci. 2024;18:1511783.

9.      Chen X, Wang Y, Li X, et al. Spinal Muscular Atrophy Diagnosis and Carrier Screening. ScienceDirect. 2020. Available from: https://www.sciencedirect.com/science/article/pii/S1098360021008662

10.  Cherington M. Clinical spectrum of botulism. Muscle Nerve. 1998;21:701–710.

11.  Day JW, Finkel RS, Chiriboga CA, et al. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol. 2021;20(4):284–293. doi:10.1016/S1474-4422(21)00001-6. PMID:33743238

12.  Dhillon S. Risdiplam: first approval. Drugs. 2020;80(17):1853–1858. doi:10.1007/s40265-020-01410-z. PMID:33044711

13.  Driscoll DJ, Miller JL, Schwartz S, et al. Prader Willi syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. University of Washington; 1993–2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1330/

14.  Dubowitz V, Sewry CA, Oldfors A. Muscle biopsy: a practical approach. Muscle Biopsy Evaluation in Neuromuscular Disorders. Neuromuscul Disord. 2015;25(8):656–665. doi:10.1016/j.nmd.2015.06.003. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4590778/

15.  Dubowitz V. Examination of the newborn. 5th ed. London: Mac Keith Press; 2013. p. 325–335.

16.  Engel AG, Shen XM. Congenital myasthenic syndromes. Handb Clin Neurol. 2013;113:1263–1273. doi:10.1016/B978-0-444-52891-9.00066-3

17.  Epstein CJ. Down syndrome (Trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. p.1223

18.   Ganguly J, Kulshreshtha D, Singh P. Muscle tone physiology and abnormalities. J Assoc Physicians India. 2021;69(5):11–6. Available from: (PMCID: PMC8071570)

19.  Genomics Education Programme. Spinal Muscular Atrophy: Classification. Health Education England; [cited 2025 Sep 23]. Available from: https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/spinal-muscular-atrophy/

20.  Gutierrez MAF. Prader-Willi syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan– [cited 2025 Sep 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553161/

21.   Jain A, Al Khalili Y. Congenital Myotonic Dystrophy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan [cited 2025 Sep 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560518/

22.   Kaler J, Hussain A, Patel S,. Neuromuscular Junction Disorders and Floppy Infant Syndrome: A Comprehensive Review. Cureus. 2020;12(2):e6922. doi:10.7759/cureus.6922

23.  Leyenaar J, Camfield P, Camfield C. A schematic approach to hypotonia in infancy. Paediatr Child Health. 2005;10(7):397–400. doi:10.1093/pch/10.7.397

24.  Low PA, McLeod JG, Pineas JW. Hypertrophic Charcot-Marie-Tooth disease. J Neurol Sci. 1978;37(2):179–190. doi:10.1016/0022-510x(78)90104-1

25.  Madhok J, Shabbir M. Hypotonia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan– [cited 2025 Sep 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562209/

26.   Madhok J, Shabbir M. Physiology of muscle energy and tone. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan– [cited 2025 Sep 23]. Available from: (PMCID: PMC559029)

27.  Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625–635. doi:10.1056/NEJMoa1710504

28.  Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. SMA Care Group.

29.  Morales RJ, Pageot N, Taieb T, et al. Adult-onset spinal muscular atrophy: An update. Rev Neurol (Paris). 2017;173:308–319

30.  Nishio H, Niba ETE, Awano H. Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment. Int J Mol Sci. 2023;24:11939. doi:10.3390/ijms241511939

31.  North K, Wang CH. Congenital myopathies. Semin Pediatr Neurol. 2013;20(4):200–210. doi:10.1016/j.spen.2013.11.005

32.  Peredo DE, Hannibal MC. The Floppy Infant: Evaluation of Hypotonia. Pediatr Rev. 2009;30(9):e66–e76. doi:10.1542/pir.30-9-e66

33.  Piña-Garza JE, James KC, editors. Fenichel’s Clinical Pediatric Neurology. 9th ed. Philadelphia: Elsevier; 2024

34.  Prior TW, Nagan N, Sugarman EA. Technical standards and guidelines for spinal muscular atrophy testing. Genet Med. 2011;13(8):686–694. doi:10.1097/GIM.0b013e318220d523. PMID:21716102

35.  Rao AK, Sobel J, Chatham-Stephens K et al. Clinical guidelines for diagnosis and treatment of botulism. MMWR Recomm Rep. 2021;70(2):1–33. doi:10.15585/mmwr.rr7002a1

36.   Royal Cornwall Hospitals Trust. Assessment of Neonatal Hypotonia – Clinical Guideline. Neonatal Clinical Guidelines, Version 2.0, 2022. Available from: https://doclibrary-rcht.cornwall.nhs.uk/DocumentsLibrary/RoyalCornwallHospitalsTrust/Clinical/Neonatal/AssessmentOfNeonatalHypotoniaClinicalGuideline.pdf

37.   Sanghera AS. Smith-Lemli-Opitz syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan– [cited 2025 Sep 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK599510/

38.   Schmid J, Beer M, Berghold A, et al.  Cardiac involvement in a cross-sectional cohort of myotonic dystrophies and other skeletal myopathies. ESC Heart Fail. 2020;7(5):2020-2031. doi:10.1002/ehf2.12763. PMID: 32476276; PMCID: PMC7373928. https://pubmed.ncbi.nlm.nih.gov/32476276/

39.  Urtizberea JA, Severa G, Malfatti E. Metabolic Myopathies in the Era of Next-Generation Sequencing. Front Neurol. 2023;14:1072344. doi:10.3389/fneur.2023.1072344. Available from: https://pubmed.ncbi.nlm.nih.gov/37239314/

40.  Verhaart IEC, Robertson A, Wilson IJ, et al. Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review. Orphanet J Rare Dis. 2017;12:124. doi:10.1186/s13023-017-0671-8. PMID:28676062; PMCID: PMC5496354